ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag faculty governance disease medicine

DNA molecule.
Finding DNA Tags in AAV Stacks
Mariella Bodemeier Loayza Careaga, PhD | Mar 7, 2024 | 8 min read
Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 
qPCRDriving Wastewater Surveillance for Infectious Disease
Nathan Ni, PhD | Oct 30, 2023 | 3 min read
Natalie Knox and the Public Health Agency of Canada’s National Microbiology Laboratory are helping establish a national qPCR-driven wastewater surveillance network for SARS-CoV-2 and other diseases.
Bespectacled man wearing black shirt with arms folded looks at camera in front of lab cabinet
Neuropathologist John Trojanowski Dies at 75
Lisa Winter | Mar 18, 2022 | 2 min read
His work was pivotal to understanding the mechanisms of neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s.
Four glass vials sit on a reflective tabletop next to a syringe. Each is labeled as a subsequent dose in a four-dose series of COVID-19 vaccines.
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines
Dan Robitzski | Aug 11, 2022 | 10+ min read
Studies show that a fourth mRNA vaccine dose offers the elderly and other high-risk groups strong protection against hospitalization and death from COVID-19, but experts say benefits for other populations may be more limited.
Government Briefs
The Scientist Staff | Jul 8, 1990 | 2 min read
Third Time's A Charm On Misconduct The scientific community learns from its mistakes in investigating allegations of misconduct - but not very quickly, says former NIH director James Wyngaarden. Wyngaarden, speaking last month at a luncheon sponsored by a National Academy of Sciences panel examining responsible conduct in research, says that he's developed a rule of thumb that predicts how institutions are likely to handle scientific misconduct by their faculty. "They blow it the first time," h
Government Briefs
The Scientist Staff | Jun 26, 1988 | 3 min read
Hitting The Magic Billion-Dollar Mark The recent AIDS report by the Institute of Medicine got a lot of play in the press for its criticism of federal efforts on behalf of drug abusers and AIDS sufferers facing discrimination. But the report also contains an important message for researchers. Entitled Confronting AIDS: Update 1988” because it follows up on IOM’s landmark 1986 report, the study calls on the NIH director to evaluate how well the government is spending its money in a s
Zebrafish with fluorescent nervous system in green.
Oust the Mouse: A Plan to Reduce Mammal Use in Drug Development
Natalia Mesa, PhD | Mar 15, 2022 | 7 min read
The Scientist spoke to Mount Desert Island Biological Laboratory’s Jim Strickland about the institute’s new MDI Bioscience initiative to perform more drug testing and development in nonmammalian models.
Lasker Award winner Piet Borst sits at his desk.
A Journey With Metabolism, Parasites, and Cancer
Laura Tran, PhD | Sep 21, 2023 | 7 min read
Piet Borst led stellar work on cell organelles, trypanosomes, and cancer drug resistance during the golden age of biology.
A rendering of a human brain in blue on a dark background with blue and white lines surrounding the brain to represent the construction of new connections in the brain.
Defying Dogma: Decentralized Translation in Neurons
Danielle Gerhard, PhD | Sep 8, 2023 | 10+ min read
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.

Run a Search

ADVERTISEMENT